A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

Carlos Alberto Calderon-Ospina,1,* Mario Hernández-Sómerson,2,* Ana María García,1 Adriana Mejia,1 Caroll Tamayo-Agudelo,1 Paul Laissue,1 Dora Janeth Fonseca Mendoza1 1Center for Research in Genetics and Genomics-CIGGUR, GENIUROS Research Group, School of...

Full description

Bibliographic Details
Main Authors: Calderon-Ospina CA, Hernández-Sómerson M, García AM, Mejia A, Tamayo-Agudelo C, Laissue P, Fonseca Mendoza DJ
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
pharmacogenomics
rhabdomyolysis
rosuvastatin
adverse drug reaction
whole-exome sequencing
polymorphisms.
Online Access:https://www.dovepress.com/a-pharmacogenomic-dissection-of-a-rosuvastatin-induced-rhabdomyolysis--peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/a-pharmacogenomic-dissection-of-a-rosuvastatin-induced-rhabdomyolysis--peer-reviewed-article-PGPM

Similar Items